AG
PROF

Advisor Group’s Profound Medical PROF Stock Holding History

Advisor Group’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2K Buy
+200
New +$1.84K ﹤0.01% 5005

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
ERIM
Eagle Ridge Investment Management Stamford, Connecticut $1.15B AUM 18.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advisor Group's PROF Position: Q4 2019 in Review

Advisor Group opened a new position in Profound Medical (PROF) in Q4 2019: 200 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #5005 among its holdings.

16 funds tracked by Wall St. Rank hold PROF as of Q4 2019.

  • Advisor Group held 200 shares of Profound Medical worth $2K as of Q4 2019.
  • Profound Medical was a new Advisor Group position in Q4 2019.
  • Profound Medical made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5005 holding.
  • 16 funds tracked by Wall St. Rank held Profound Medical as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.